A World Apart Understanding Differences in E.U. and U.S. Medical Device Adverse Event Reporting

Quantity Discounts
1 - 9999
1 - 9999
Back By Popular Demand!
An FDAnews
Webinar Rebroadcast

Our buyers have spoken – and we’re responding. By popular demand, FDAnews is rebroadcasting this best-selling event from earlier in 2011.

It’s your best opportunity – and last chance – to attend one of our highest-rated events this year.

More than 150 attended this invaluable webinar the first time around. Here’s what one of our satisfied registrants had to say:

“I liked the reportability in US and EU.”
            Utpal Khambholja, Medical Officer, ASP

Wrap up your 2011 on a high note … with this special one-time-only encore presentation.

The FDA estimated that more than 10,000 adverse event reports for medical devices are submitted annually in the U.S., with an even higher number reported in the E.U.

Failure to understand adverse event reporting in either the U.S. or the E.U. can result in faulty clinical trials and warning letters.

Make an important decision today. Learn how to bulletproof your adverse event reporting protocols by attending this upcoming webinar.

Device manufacturers: Here’s a test of your basic knowledge.

  1. In the U.S., electronic reporting of adverse events is optional. In E.U. nations, electronic reporting is:
    • Optional
    • Mandatory
    • Don’t know
  1. The EU rules for reporting adverse events that result from user error or off-label use of a device are:
    • Same as the FDA’s
    • Different from FDA’s
    • Don’t know

Put down your pencil ... but don’t relax. The real-life stakes are high — much, much higher than in a pop quiz.

If you market medical devices in E.U. countries — and who doesn’t? — you need to know E.U. regulations as thoroughly as you understand FDA regulations.

Bet you don’t, though. So here’s how to get a running start.

Mark your calendar for Tuesday, Dec. 6, 2011, when FDAnews presents A World Apart: Understanding Differences in E.U. and U.S. Medical Device Adverse Event Reporting.

Two experienced lawyers — one in Washington, Steven Datlof, MD, JD, the other in Brussels, Elisabethann Wright, BL — will lead the session and spell out where and how FDA and EMA rules differ ... and where they’re similar.

In just 90 minutes, you’ll discover key areas of compliance, as well as penalties for failing to observe them. You’ll learn:

  • Specifics of the European Medical Devices Vigilance System and FDA’s MDR rules, 21 CFR Part 803
  • Similarities and differences in incident reporting under the E.U. and U.S. systems
  • How to perfect your reporting procedures to work under both U.S. and E.U. rules
  • The most common EMA reporting errors and how to avoid them
  • Consequences of not meeting your reporting obligations under each system, and risks of under-reporting and over-reporting
  • How to ensure patient safety and avoid the penalties of noncompliance
  • And much more

A World Apart: Understanding Differences in E.U. and U.S. Medical Device Adverse Event Reporting is convenient to attend. All that’s required is that you be in front of a screen at the appointed time, whether you work at the office or telecommute from your office at home.

Key people throughout your company will benefit from taking part in this event. Best of all, everyone can do so at a cost that won’t break the budget. You pay one single low registration fee per facility, regardless of how many participate. So spread the word.

FDA warning letters and 483s are bad enough without EMA sanctions too. Why take the risk? Start learning what you need to know. Register now for this bi-continental regulatory boot camp.

The list of those who will benefit from this webinar is a long one, including (but not limited to):

  • Medical Directors
  • Study Directors
  • Compliance officers
  • Executive management
  • General/corporate counsel
  • Personnel new to the industry
  • QA/QC personnel
  • Regulatory/legislative affairs professionals
  • Risk management specialists
  • Strategic planning and business development staff
  • Training personnel
  • Academic researchers

Steven Datlof, MD, JD, is a partner in the Philadelphia office of Hogan Lovells. His practice focuses on FDA regulation of medical devices, pharmaceuticals and biologicals. He works with companies to develop regulatory strategies for obtaining FDA marketing approval for their products and represents them before the agency. A physician as well as a lawyer, Mr. Datlof focuses on counseling related to the intersection of regulatory, legal, and clinical issues.

Elisabethann Wright, BL, is a partner in the Brussels office of Hogan Lovells International.  Her experience in European law includes both private practice and work with international institutions. She focuses on European Union (E.U.) law relating to life sciences, emphasizing pharmaceutical law, medical devices, food law, and the environment.

Register now!

Date: Tuesday, Dec. 6, 2011
Location: Your office or conference room (no need to travel!)
Time: 1:30 p.m. – 3:00 p.m. EST
  12:30 p.m. – 2:00 p.m. CST
  11:30 a.m. – 1:00 p.m. MST
  10:30 a.m. – 12:00 p.m. PST
  6:30 p.m. – 8:00 p.m. GMT

Gather your team for maximum benefit! Your investment is for one dial-in.

Interested in registering multiple sites?

Significant tuition discounts are available for three or more sites from
the same company. You must register at the same time and
provide a single payment to take advantage of the discount. Register below
by clicking on add to cart and then change your quantity in the shopping cart.
The discount will be calculated automatically.

3-4 sites – 10%
7-9 sites – 20%
5-6 sites – 15%
10+ sites – 25%

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
with any questions.

We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.

Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Registrations may not be cancelled. Please contact customer service to make any substitutions.

Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.